Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

10-Hour eating window may stop weight regain, new study tests

NCT ID NCT07163455

Disease control Sponsor: Harbin Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 26, 2026 · Updated 2 times

Summary

This study tests whether limiting eating to a 10-hour window each day helps overweight or obese adults maintain weight loss after losing at least 5% of their body weight. About 500 participants across China will follow either the time-restricted eating plan or standard weight-maintenance advice for 12 months. Researchers will track weight, body composition, and overall health to see if the eating window makes a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants who meet all the following conditions will be included in the trial: 1. BMI ≥ 28.0 kg/m², or BMI between 24.0-27.9 kg/m² with at least one weight-related comorbidity. 2. Age: 18-65 years. 3. Weight Loss Plan: Willing to undergo a structured weight-loss program. Exclusion Criteria: * Participants who meet any of the following conditions will be excluded from the trial: 1. Infectious Diseases: History of HIV/AIDS, active hepatitis B/C, or active tuberculosis. 2. Malignancy: History of any malignancy. 3. Organ Dysfunction:Severe hepatic impairment.Chronic kidney disease. 4. Cardiovascular/Cerebrovascular Events: History of angina, myocardial infarction, or stroke within the past 6 months. 5. Gastrointestinal Conditions:Severe gastrointestinal diseases (e.g., inflammatory bowel disease).Gastrointestinal surgery within the past 12 months. 6. Endocrine Disorders:Cushing's syndrome, hypothyroidism, acromegaly, or hypothalamic obesity. 7. Medications: Use of drugs affecting weight/energy balance (e.g., antipsychotics, weight-loss medications) within the past 6 months. 8. Pregnancy/Lactation: Currently pregnant, planning pregnancy, or breastfeeding. 9. Compliance Issues: Inability to complete the study (due to health, immigration, or other reasons). 10. Informed Consent: Unwilling or unable to provide informed consent. 11. Weight Stability: \>5% change in body weight within the past 6 months. 12. Individuals unable to use or operate a smartphone

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight or obese adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overweight or obese adults

Contacts and locations

Locations

  • Army Medical Center of PLA

    Chongqing, Chongqing Municipality, 400010, China

  • Chengdu Seventh People's Hospital

    Chengdu, Sichuan, 610213, China

  • Harbin Medical University

    Harbin, Heilongjiang, 150081, China

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, 518020, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, 266000, China

  • The Fifth Medical Center of Chinese PLA General Hospital

    Beijing, Beijing Municipality, 100071, China

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150001, China

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150086, China

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, 710004, China

  • Weifang People's Hospital

    Weifang, Shandong, 261041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.